Imperial College London

DrLukeTyson

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Research Postgraduate
 
 
 
//

Contact

 

l.tyson CV

 
 
//

Location

 

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Summary

Gastroenterology and Hepatology Specialty Registrar (North West London), Honorary Clinical Research Fellow and PhD student at Imperial College London. My research supervisors are Professor Mark Thursz and Professor Elaine Holmes. My research interests include alcohol-related liver disease, alcoholic hepatitis, and the application of metabolomics to liver disease.

Publications

Journals

Tyson LD, Lewis H, 2022, Response to 'acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?', European Journal of Gastroenterology & Hepatology, Vol:34, ISSN:0954-691X, Pages:976-976

Smith PJ, 2022, GI highlights from the literature, Gut, ISSN:0017-5749

Tyson LD, Cheng A, Kelleher C, et al., 2022, Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice, European Journal of Gastroenterology & Hepatology, Vol:34, ISSN:0954-691X, Pages:567-575

Atkinson SR, Aly M, Remih K, et al., 2022, Serum keratin 19 (CYFRA21-1) is a prognostic biomarker in severe alcoholic hepatitis, Liver International, Vol:42, ISSN:1478-3223, Pages:1049-1057

Conference

Tyson L, Thursz PM, Forrest E, et al., 2021, INCIDENT ACUTE KIDNEY INJURY HAS A WORSE PROGNOSIS THAN BASELINE IN SEVERE ALCOHOLIC HEPATITIS, BMJ PUBLISHING GROUP, Pages:A25-A26, ISSN:0017-5749

More Publications